Sativa Group PLC - Phytovista completes largest UK CBD product test
("Sativa" or "
Phytovista subsidiary completes largest
PhytoVista's technicians used its state of the art analytical equipment to report back to the CMC on the quality of the samples being asked to focus on the areas of health & safety, consumer rights, and criminal law. The results are contained within the CMC report 'CBD in the
The test utilised PhytoVista's standard analysis process, which produces a Certificate of Analysis capable of reporting by product on pesticides, heavy metals, residual solvents, cannabinoids, terpenes and mycotoxins, and Tetrahydrocannabinol (THC) content. Each
For the CMC, PhytoVista was asked to test specifically for heavy metals, residual solvents and cannabinoids.
PhytoVista reported the results to the CMC and the detailed conclusions are contained within the CMC report (see below for contact details). The process however was most revealing in terms of quality and instances of poor practice. The biggest issues related to accuracy of labelling, the presence of controlled substances and some contaminants, and in one sample the complete absence of any CBD, a result validated by the CMC through a second independent laboratory test.
38% of the products tested had less than 50% of the advertised CBD content. One product had 0% CBD. 45% of the selected products had measurable levels of THC (mean content 0.04%) or CBN (mean content 0.01%) and are thus technically illegal within the
One product had 3.8% ethanol (3.4% qualifies as an alcoholic beverage). Dichoromethane was detectable in seven products (3.8-13.1ppm) and cyclohexane was found in one product (27.9ppm). These percentages of solvents and heavy metals are still below the permitted daily dose levels in pharmaceutical products, although above food limit safety levels.
Conversely, George Botanicals, another Sativa subsidiary and a wholesaler and on-line retailer of CBD products, can guarantee that all of its products have been batch tested independently by PhytoVista. Sativa subsidiary Goodbody Wellness opens its first high street CBD wellness store in
to Executive Summary
- Ends -
For further information please contact:
Founder & Chief Executive Officer
+44 (0) 20 7971 1255
Chief Financial Officer
+44 (0) 20 7971 1255
NEX Exchange Corporate Adviser
Cenkos Securities plc
+44 (0) 20 7397 8900
+44 (0) 20 7397 8900
Financial PR and IR
+44 (0) 7771 663 886
Notes to Editors
Sativa is a seed to Consumer medicinal cannabis and cannabidiol (CBD) wellness business, focused on the smart-sourcing of the raw material, advanced extraction, manufacture, testing, distribution, and research & development of medicinal cannabis and CBD products. The Company has a Home Office licence application in process which, when granted as the Directors believe it will be as the application is in its final stages, will enable the Company to engage in the highly regulated process of growing, strictly for medicinal research & development purposes only, Tetrahydrocannabinol (THC) rich cannabis flowers at its high-security
The Company joined the
Phytovista has conducted over 1000 independent tests and George Botanicals develops, manufactures and distributes low-THC CBD wellness products. Other important future revenue streams are at various stages of development from concept to actual launch, with the first Goodbody CBD wellness centre opening in
Prior to the Listing, Sativa's founder and CEO,
Sativa has a highly experienced
The Company has a strong senior management team and Board team including Joseph Colliver FCA as Chief Financial Officer and a Board Director, and
Sativa's smart-sourcing strategy enables it to define the crucial factors of seed strain, growing techniques and environment, along with extraction methods, all of which are imperative to the quality of the end-product.
The Group's activities include the
Sativa has invested in two Canadian-based businesses, pharmaceutical company
For more information on Sativa Investments, please visit: www.sativainvestments.co.uk
· Ends -
This information is provided by RNS, the news service of the
Quick facts: Sativa Group PLC
Market Cap: -
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...FOR OUR FULL DISCLAIMER CLICK HERE